BRPI0706801B8 - método de purificação de cardiomiócitos ou cardiomiócitos programados derivado de células-tronco ou fetos - Google Patents

método de purificação de cardiomiócitos ou cardiomiócitos programados derivado de células-tronco ou fetos

Info

Publication number
BRPI0706801B8
BRPI0706801B8 BRPI0706801A BRPI0706801A BRPI0706801B8 BR PI0706801 B8 BRPI0706801 B8 BR PI0706801B8 BR PI0706801 A BRPI0706801 A BR PI0706801A BR PI0706801 A BRPI0706801 A BR PI0706801A BR PI0706801 B8 BRPI0706801 B8 BR PI0706801B8
Authority
BR
Brazil
Prior art keywords
cardiomyocytes
condition
stem cells
fetuses
derived
Prior art date
Application number
BRPI0706801A
Other languages
English (en)
Inventor
Hattori Fumiyuki
Fukuda Keiichi
Original Assignee
Asubio Pharma Co Ltd
Daiichi Sankyo Co Ltd
Heartseed Inc
Univ Keio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asubio Pharma Co Ltd, Daiichi Sankyo Co Ltd, Heartseed Inc, Univ Keio filed Critical Asubio Pharma Co Ltd
Publication of BRPI0706801A2 publication Critical patent/BRPI0706801A2/pt
Publication of BRPI0706801B1 publication Critical patent/BRPI0706801B1/pt
Publication of BRPI0706801B8 publication Critical patent/BRPI0706801B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657—Cardiomyocytes; Heart cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14—Calcium; Ca chelators; Calcitonin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/44—Thiols, e.g. mercaptoethanol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

método de purificação de cardiomiõcitos ou cardiomiócitos programados derivado de células- tronco ou fetos a presente invenção refere-se ao desenvolvimento de um método para purificar cardiomiácitos com alto grau de purificação e com alto rendimento a partir de uma mistura celular compreendendo cardiomiócitos derivados de fetos e de células-tronco usando várias características as quais não foram anteriormente esperadas para serem usadas para a purificação de cardiomiócitos, ou as quais são recentemente descobertas, em que o referido método é executado sem sofrer qualquer modificação genética ou sem adicionar quaisquer proteínas ou agentes biologicamente ativos especiais. os inventores da presente invenção descobriram que os cardio-miócitos foram altamente selecionados e purificados de forma eficaz pelo cultivo de cardiomiácitos derivados de células-tronco embrionárias no meio de cultura sob uma condição selecionada de uma condição selecionada com pouco soro, uma condição suplementada com pouca glicose, uma condição nutricional baixa, uma condição com pouco cálcio, uma condição com ph brandamente ácido, uma condição suplementada com ácido lático, uma condição suplementada com ácido aspártico/ácido glutâmico e/ou uma condição suplementada com ácido pirúvico. os inventores da presente invenção ainda descobriram que o método inventado acima, em relação às células-tronco embrionárias, foi aplicável para selecionar e purificar cardiomiácitos derivados de fetos ou de células-tronco adultas.
BRPI0706801A 2006-01-31 2007-01-31 método de purificação de cardiomiócitos ou cardiomiócitos programados derivado de células-tronco ou fetos BRPI0706801B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006-023770 2006-01-31
JP2006023770 2006-01-31
PCT/JP2007/051563 WO2007088874A1 (ja) 2006-01-31 2007-01-31 幹細胞及び胎児由来の心筋細胞及び予定心筋細胞の精製方法

Publications (3)

Publication Number Publication Date
BRPI0706801A2 BRPI0706801A2 (pt) 2011-04-05
BRPI0706801B1 BRPI0706801B1 (pt) 2020-04-07
BRPI0706801B8 true BRPI0706801B8 (pt) 2021-05-25

Family

ID=38327445

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0706801A BRPI0706801B8 (pt) 2006-01-31 2007-01-31 método de purificação de cardiomiócitos ou cardiomiócitos programados derivado de células-tronco ou fetos

Country Status (12)

Country Link
US (1) US9115342B2 (pt)
EP (2) EP1983042B1 (pt)
JP (2) JP5312804B2 (pt)
KR (2) KR101348325B1 (pt)
CN (2) CN101374942A (pt)
AU (1) AU2007210580B2 (pt)
BR (1) BRPI0706801B8 (pt)
CA (1) CA2640644C (pt)
IL (1) IL193095A (pt)
RU (1) RU2426784C2 (pt)
SG (1) SG169359A1 (pt)
WO (1) WO2007088874A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007026353A2 (en) 2005-08-29 2007-03-08 Technion Research & Development Foundation Ltd. Media for culturing stem cells
EP1983042B1 (en) * 2006-01-31 2017-03-15 Daiichi Sankyo Company, Limited A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses
DK2733203T3 (en) 2006-08-02 2019-02-04 Technion Res & Dev Foundation PROCEDURES FOR EXPANSION OF EMBRYONAL STEM CELLS IN A SUSPENSION CULTURE
CN102449139B (zh) 2009-03-30 2016-08-24 第一三共株式会社 对多能性干细胞和心肌细胞以外的分化细胞诱导细胞死亡的方法
WO2011058558A2 (en) 2009-11-12 2011-05-19 Technion Research & Development Foundation Ltd. Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
AU2011268056B2 (en) 2010-06-18 2014-04-24 Cellular Dynamics International, Inc. Cardiomyocyte medium with dialyzed serum
KR101364965B1 (ko) * 2010-10-06 2014-02-18 (주)차바이오앤디오스텍 인간 배아줄기세포 유래 심근세포의 배양 및 정제 방법
JP5840855B2 (ja) 2011-03-30 2016-01-06 学校法人東京女子医科大学 胚性幹細胞から心筋シートを製造する方法
US9034584B2 (en) * 2011-07-29 2015-05-19 Cellular Dynamics International, Inc. Metabolic maturation in stem cell-derived tissue cells
ES2523903B1 (es) * 2013-04-30 2015-09-09 Fundación Pública Andaluza Progreso Y Salud Método de obtención de datos útiles para el diagnóstico diferencial de la fibrosis hepática
CN105039399A (zh) * 2014-04-23 2015-11-11 复旦大学 多能干细胞-遗传性心肌病心肌细胞及其制备方法
AU2015290571B2 (en) * 2014-07-16 2021-03-04 Heartseed Inc. New undifferentiated stem cell removal and myocardial purification and refinement culture medium
US10696948B2 (en) 2014-09-16 2020-06-30 Osaka University Method for preparing pluripotent stem cell-derived cardiomyocyte population
US20170335284A1 (en) * 2014-11-07 2017-11-23 Osaka University Differentiation-induced cell population from which undifferentiated cells have been removed, use of same, and method for producing same
JP6622007B2 (ja) * 2015-05-29 2019-12-18 オリンパス株式会社 細胞評価方法
WO2017207576A1 (en) 2016-06-01 2017-12-07 Miltenyi Biotec Gmbh Process for generation, identification and isolation of human pluripotent stem cell-derived cardiomyocytes and cardiomyocyte subpopulations
CN106244527B (zh) * 2016-08-29 2019-10-08 广东依浦赛生物科技有限公司 人源iPS干细胞体外定向分化为心肌细胞的试剂盒及方法
CA3040637C (en) * 2016-10-17 2023-02-28 Keio University Undifferentiated stem cell-removing agent, and method for removing undifferentiated stem cells
JP6426327B2 (ja) 2016-11-01 2018-11-21 テルモ株式会社 接着状態の細胞培養物の改変方法
CN106754663A (zh) * 2016-11-30 2017-05-31 中国人民解放军第三军医大学第三附属医院 促进成年哺乳动物心肌细胞存活的体外培养方法及监测成年哺乳动物心肌细胞增殖的方法
JP2018093823A (ja) 2016-12-15 2018-06-21 Heartseed株式会社 未分化幹細胞除去剤及び未分化幹細胞除去方法
KR101879517B1 (ko) * 2016-12-27 2018-07-17 전남대학교병원 중간엽 줄기세포를 심근세포로 분화시키는 방법
WO2018225705A1 (ja) 2017-06-05 2018-12-13 テルモ株式会社 細胞培養物の製造方法
CN107828721A (zh) * 2017-11-10 2018-03-23 山东农业大学 一种鸡胚心肌细胞的培养及免疫组织化学鉴定方法
WO2020067435A1 (ja) * 2018-09-27 2020-04-02 国立大学法人大阪大学 多能性幹細胞由来細胞のシート化方法
JP7781522B2 (ja) * 2018-09-27 2025-12-08 国立大学法人大阪大学 多能性幹細胞由来細胞のシート化方法
JP7748804B2 (ja) * 2018-09-27 2025-10-03 国立大学法人大阪大学 多能性幹細胞由来細胞の移植片形成方法
CN110904024A (zh) * 2019-11-13 2020-03-24 武汉济源高科技有限公司 一种悬浮细胞培养中去除死细胞的方法
CN111621470B (zh) * 2020-06-08 2023-06-27 广东源心再生医学有限公司 一种高效低毒的心肌纯化培养基及方法
CN114591895B (zh) * 2022-04-12 2025-07-22 澳门大学 一种诱导干细胞分化为心肌细胞的方法及其培养基组合
CA3260212A1 (en) 2022-07-05 2024-01-11 Repairon Gmbh DIFFERENTIATION OF CSPI IN BIOREACTORS
CN121586768A (zh) 2023-05-30 2026-02-27 心脏康复株式会社 心肌细胞群、药物组合物、制备心肌细胞群的方法和心肌细胞球体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL47012C (pt) 1933-03-23
GB9903804D0 (en) 1999-02-20 1999-04-14 Univ Sheffield Pluripotential cells-2
EP1254952A4 (en) 1999-12-28 2004-09-22 Kyowa Hakko Kogyo Kk CELLS THAT ARE ABLE TO DIFFERENTIZE IN THE HEART MUSCLE CELLS
KR20030088022A (ko) 2000-11-30 2003-11-15 스템론 인크. 단리된 동종접합 간세포, 그로부터 유래된 분화 세포 및이들을 제조 및 사용하기 위한 물질 및 방법
US7732199B2 (en) * 2001-07-12 2010-06-08 Geron Corporation Process for making transplantable cardiomyocytes from human embryonic stem cells
EP1412479A4 (en) * 2001-07-12 2004-07-28 Geron Corp CELLS WITH CARDIOMYOCYTE GENERATION PRODUCED FROM HUMAN PLURIPOTENT STEM CELLS
GB2427873B (en) * 2004-03-19 2008-09-10 Geron Corp Method for making high purity cardiomyocyte preparations suitable for regenerative medicine
EP1756268A4 (en) * 2004-06-01 2007-12-12 Es Cell Int Pte Ltd IMPROVED CARDIOMYOCYTE DIFFERENTIATION
EP1838844A4 (en) * 2004-12-22 2008-11-26 Ip Organisers Pty Ltd DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND CARDIOMYOCYTES AND CARDIOMYOCYTIC DERIVATIVES DERIVED THEREFROM
EP1983042B1 (en) * 2006-01-31 2017-03-15 Daiichi Sankyo Company, Limited A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses

Also Published As

Publication number Publication date
RU2426784C2 (ru) 2011-08-20
KR20080097197A (ko) 2008-11-04
WO2007088874A1 (ja) 2007-08-09
SG169359A1 (en) 2011-03-30
EP1983042A4 (en) 2009-06-17
IL193095A0 (en) 2009-02-11
JP2013143968A (ja) 2013-07-25
CN103409368A (zh) 2013-11-27
BRPI0706801B1 (pt) 2020-04-07
JP5312804B2 (ja) 2013-10-09
EP2468851A1 (en) 2012-06-27
JP5756145B2 (ja) 2015-07-29
KR101348325B1 (ko) 2014-01-08
BRPI0706801A2 (pt) 2011-04-05
KR20120123608A (ko) 2012-11-08
CA2640644C (en) 2013-11-26
US9115342B2 (en) 2015-08-25
CN101374942A (zh) 2009-02-25
KR101455144B1 (ko) 2014-10-27
CA2640644A1 (en) 2007-08-09
US20090275132A1 (en) 2009-11-05
RU2008135313A (ru) 2010-03-20
CN103409368B (zh) 2016-05-25
JPWO2007088874A1 (ja) 2009-06-25
EP1983042B1 (en) 2017-03-15
AU2007210580A1 (en) 2007-08-09
IL193095A (en) 2015-06-30
AU2007210580B2 (en) 2012-10-11
EP1983042A1 (en) 2008-10-22

Similar Documents

Publication Publication Date Title
SG169359A1 (en) A method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses
EA201101581A1 (ru) Улучшенный способ культивирования клеток
NZ597334A (en) Cell culture improvements
BRPI0516572A (pt) métodos e composições para melhorar a produção de proteìnas recombinantes
EA200970263A1 (ru) Полностью человеческая высокопродуктивная система получения усовершенствованных антител и белков
BRPI0506369A (pt) microorganismos, e, métodos para produzir um l-aminoácido
DE602007005233D1 (de) Verfahren zur herstellung von l-aminosäure
NZ587023A (en) Composition comprising protein and disperse fat
BR112015017307A2 (pt) composições de espécies com baixa acidez e métodos para produção e uso das mesmas
ATE512990T1 (de) Verfahren zur herstellung von gereinigten beta-(1,3)-d-glucanen
MY158628A (en) Fermentation product containing equol-producing microorganism having maintained equol-producing ability, and method for producing same
RU2015144020A (ru) Среды для культивирования клеток и способы получения антител
BRPI0511482A (pt) incorporação sìtio-especìfica de aminoácidos artificiais contendo átomos pesados em proteìnas para determinação de estrutura cristalina
UA92157C2 (ru) Способ продуцирования гормона роста
SI2126106T1 (en) A process for the production and purification of factor VIII and its derivatives
BR9904104A (pt) Método para enzima de formação de sacarìdeo irredutìvel, enzima de liberação de trehalose, e processo para produção de sacarìdeos empregando as enzimas
ATE495676T1 (de) Mikroorganismus und verfahren zur herstellung von l-methionin
BR112013004396A2 (pt) alimentação alcalina
MX395311B (es) Metodo para producir factor de crecimiento de hepatocitos (hgf) activo.
ATE536347T1 (de) Effiziente herstellung heterologer proteine unter verwendung von mannosyltransferaseinhibitoren
BR112012007605A2 (pt) Mistura baseada em levedura
ES2743548B1 (es) Procedimiento para mejorar la producción de metano a partir de microalgas
RU2008152363A (ru) Способ культивирования продуцента липазы
Wang et al. Investigation of algal cultivation and anaerobic co-digestion of sewage sludge and algae at wastewater treatment plant (WWTP)
MD3101G2 (ro) Procedeu de obţinere a biomasei de Spirulina platensis

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: KEIO UNIVERSITY (JP) , DAIICHI SANKYO COMPANY, LIM

Free format text: TRANSFERIDO POR FUSAO DE: ASUBIO PHARMA CO., LTD.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B25A Requested transfer of rights approved

Owner name: DAIICHI SANKYO COMPANY, LIMITED (JP) , HEARTSEED I

B15K Others concerning applications: alteration of classification

Ipc: C12N 5/077 (2010.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 07/04/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/01/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF